Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Molecular Diagnostics for Transplant Companies

Molecular diagnostics for transplantation typically involves the use of genetic and molecular techniques to assess compatibility between donors and recipients, monitor transplant rejection, and optimize post-transplant care. Companies operating in this space may offer a range of products and services, including genetic testing, next-generation sequencing, and other advanced molecular diagnostic technologies.

Molecular Diagnostics for Transplant Key Companies

Latest Molecular Diagnostics for Transplant Companies Update:

Natera Expanded its Prospera product line with Prospera with Quantification, the first commercially available cfDNA (cell-free DNA) test for non-invasive monitoring of kidney transplant rejection.

CareDx Received FDA approval for AlloMap Heart Care™, a next-generation gene expression test that improves the prediction of cardiac allograft vasculopathy (CAV) development after heart transplant.

Thermo Fisher Scientific Launched the TruSight Transplant One™ Kit, a comprehensive NGS (next-generation sequencing) assay enabling simultaneous analysis of HLA (human leukocyte antigen) typing, CMV (cytomegalovirus) and EBV (Epstein-Barr virus) detection, and chimerism testing in transplant patients.

List of Molecular Diagnostics for Transplant Key companies in the market

Thermo Fisher Scientific Inc. (US)

BioMérieux SA (France)

Cepheid (US)

Altona Diagnostics GmbH (Germany)

ELITechGroup (France)

Hoffmann-La Roche Ltd. (Switzerland)

Hologic Inc. (US)

QIAGEN N.V. (Germany)

Becton, Dickinson, and Company (US)

Abbott Laboratories, Inc. (US)

Molecular Diagnostics for Transplant Market Highlights:

Molecular Diagnostics for Transplant Market Size

Molecular Diagnostics for Transplant Market Trends

Molecular Diagnostics for Transplant Market Analysis

Molecular Diagnostics for Transplant Market Share

Molecular Diagnostics for Transplant Market Highlights:

Molecular Diagnostics for Transplant Market Trends

Molecular Diagnostics for Transplant Market Analysis

Molecular Diagnostics for Transplant Market Share

Molecular Diagnostics for Transplant Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.